Category Archive for Interesting Reads
For opinion pieces and round-ups
WHO makes cancer recommendations
The World Health Organization (WHO) has explained its priorities to help save seven million people from cancer-related deaths. The WHO … read more »
Medicine designed by AI to progress to human trials
British company shows artificial intelligence (AI) cuts drug development time and can lead to clinical trials in as little as … read more »
ICER launches framework for Value Assessment
The influential Institute for Clinical and Economic Review (ICER) has completed its work to define a new Value Assessment Framework, … read more »
Industry bodies remain concerned over pricing policies in USA
The proposal for an International Price Index (IPI) remains prominent in discussions over how to control drug prices in the … read more »
NICE appoints interim chair
The National Institute for Health and Care Excellence (NICE) has appointed Tim Irish to lead its board during the final … read more »
NICE team publish paper on using patient preference studies in HTE decision making
A team from NICE have published a perspective paper on how to make use of patient preference studies in health … read more »
AMR Industry Alliance present progress report
International group launches its 2020 progress report detailing where global health has had success in the fight against drug-resistant pathogens. … read more »
Study suggests regulatory innovations have not accelerated drug development timelines
A study has been published in JAMA examining the the impact of innovations such as expedited approval on the total … read more »
Update on Life Sciences Industrial Strategy published
The Office for Life Sciences (OLS) has given its verdict on the progress achieved towards the Life Sciences Industrial Strategy, … read more »
Office for Health Economics examines the ethics of ultra-orphan appraisals
The Office for Health Economics (OHE) has released a report in which it examines the ethics behind the way medicines … read more »
